Azaya Therapeutics Inc., an oncology company focused on developing cancer treatments through its nanotechnology platform, has launched Parexo Labs, a CDMO providing chemical testing and liposomal manufacturing services to outside organizations. Parexo Labs will leverage Azaya’s capabilities in cytotoxic and nanoparticle analysis and liposome manufacturing, including its proprietary analytical methodology to detail release rates and characterization attributes of nanoparticles. Parexo Labs offer...